Insider Transactions Reported by 25 Insiders of Passage BIO, Inc.

Symbol
PASG on Nasdaq
Location
Philadelphia, PA

Insiders trading volume in the past year

Passage BIO, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lynx1 Capital Management LP 10%+ Owner $4,359,379 +$223,735 +5.4% 11 Sep 2025
ORBIMED ADVISORS LLC 10%+ Owner $2,001,893 -$325,674 -14% 24 Jun 2025
Jill M. Quigley Chief Operating Officer $338,849 08 Dec 2021
William Chou PRESIDENT AND CEO, Director $58,650 08 Jan 2026
Mark S. Forman Chief Medical Officer $56,272 15 Mar 2024
Alexandros Fotopoulos Chief Technical Officer $48,861 15 Jun 2023
Kathleen Borthwick Cfo $48,563 08 Jan 2026
Simona King Chief Financial Officer $21,835 28 Jul 2023
Monika Maria Toernsen Chief Commercial Officer $16,670 15 Sep 2022
Richard Morris Chief Financial Officer $4,963 21 May 2021
Eliseo Oreste Salinas Chief Res. & Develop Officer 10 Feb 2022
Athena Countouriotis Director 28 May 2025
MAXINE GOWEN Director 28 May 2025
Brian Burkavage Controller 30 May 2021
Liam Ratcliffe Director 27 May 2021
Derrell Porter Director 28 May 2025
Thomas Richard Kassberg Director 28 May 2025
Michael E. Kamarck Director 25 May 2023
Bruce A. Goldsmith CEO and President, Director 27 May 2022
Thomas Woiwode Director, 10%+ Owner 25 May 2023
Saqib Islam Director 28 May 2025
Sandip Kapadia Director 28 May 2025
Dolan Sondhi Director 28 May 2025
Edgar B. Cale Gc & Corporate Secretary 15 Mar 2025
Tadataka Yamada Director 27 May 2021

Recent Insider Transactions by Companies or Individuals for Passage BIO, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.